NFE2L2 and glioblastoma: In a study, PDI inhibitor pyrimidotriazinedione 35G8 suppressed PDI target genes such as EGR1 and TXNIP in human glioblastoma cells, activated Nrf2-mediated antioxidant response and ER stress response [140].